These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38277483)

  • 21. Amino acids and mTOR mediate distinct metabolic checkpoints in mammalian G1 cell cycle.
    Saqcena M; Menon D; Patel D; Mukhopadhyay S; Chow V; Foster DA
    PLoS One; 2013; 8(8):e74157. PubMed ID: 23977397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Knockdown of Hypoxia-Inducible Factor 1α (HIF-1α) Promotes Autophagy and Inhibits Phosphatidylinositol 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Signaling Pathway in Ovarian Cancer Cells.
    Huang J; Gao L; Li B; Liu C; Hong S; Min J; Hong L
    Med Sci Monit; 2019 Jun; 25():4250-4263. PubMed ID: 31175269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of Aerobic Glycolysis Represses Akt/mTOR/HIF-1α Axis and Restores Tamoxifen Sensitivity in Antiestrogen-Resistant Breast Cancer Cells.
    Woo YM; Shin Y; Lee EJ; Lee S; Jeong SH; Kong HK; Park EY; Kim HK; Han J; Chang M; Park JH
    PLoS One; 2015; 10(7):e0132285. PubMed ID: 26158266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic hypoxia-induced alterations of key enzymes of glucose oxidative metabolism in developing mouse liver are mTOR dependent.
    Dukhande VV; Sharma GC; Lai JC; Farahani R
    Mol Cell Biochem; 2011 Nov; 357(1-2):189-97. PubMed ID: 21625955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of mTOR complexes protects cancer cells from glutamine starvation induced cell death by restoring Akt stability.
    Khan MW; Layden BT; Chakrabarti P
    Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt A):2040-2052. PubMed ID: 29555211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glutamine metabolism targeting liposomes for synergistic chemosensitization and starvation therapy in ovarian cancer.
    Cai X; Shi S; Chen G; Zhong M; Yang Y; Mai Z; Tian Y; Tan J; He L; Cui C; Yu Z; Wang X
    Acta Biomater; 2023 Mar; 158():560-570. PubMed ID: 36596434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nano-realgar suppresses lung cancer stem cell growth by repressing metabolic reprogramming.
    Yang FR; Zhao YF; Hu XW; Liu ZK; Yu XD; Li CY; Li XR; Li HJ
    Gene; 2021 Jul; 788():145666. PubMed ID: 33887368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic Constants and Plasticity of Cancer Cells in a Limiting Glucose and Glutamine Microenvironment-A Pyruvate Perspective.
    Otto AM
    Front Oncol; 2020; 10():596197. PubMed ID: 33425750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperactivation of mammalian target of rapamycin complex 1 (mTORC1) promotes breast cancer progression through enhancing glucose starvation-induced autophagy and Akt signaling.
    Chen Y; Wei H; Liu F; Guan JL
    J Biol Chem; 2014 Jan; 289(2):1164-73. PubMed ID: 24275666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting the mTOR pathway in breast cancer.
    Liu J; Li HQ; Zhou FX; Yu JW; Sun L; Han ZH
    Tumour Biol; 2017 Jun; 39(6):1010428317710825. PubMed ID: 28639903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PDK1-Dependent Metabolic Reprogramming Dictates Metastatic Potential in Breast Cancer.
    Dupuy F; Tabariès S; Andrzejewski S; Dong Z; Blagih J; Annis MG; Omeroglu A; Gao D; Leung S; Amir E; Clemons M; Aguilar-Mahecha A; Basik M; Vincent EE; St-Pierre J; Jones RG; Siegel PM
    Cell Metab; 2015 Oct; 22(4):577-89. PubMed ID: 26365179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cellular response to glutamine and/or glucose deprivation in in vitro transformed human fibroblasts.
    Chiodi I; Picco G; Martino C; Mondello C
    Oncol Rep; 2019 Jun; 41(6):3555-3564. PubMed ID: 31002368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LAT2 regulates glutamine-dependent mTOR activation to promote glycolysis and chemoresistance in pancreatic cancer.
    Feng M; Xiong G; Cao Z; Yang G; Zheng S; Qiu J; You L; Zheng L; Zhang T; Zhao Y
    J Exp Clin Cancer Res; 2018 Nov; 37(1):274. PubMed ID: 30419950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of hypoxia-inducible factor 1alpha expression and function by the mammalian target of rapamycin.
    Hudson CC; Liu M; Chiang GG; Otterness DM; Loomis DC; Kaper F; Giaccia AJ; Abraham RT
    Mol Cell Biol; 2002 Oct; 22(20):7004-14. PubMed ID: 12242281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impairment of HIF-1α-mediated metabolic adaption by NRF2-silencing in breast cancer cells.
    Lee S; Hallis SP; Jung KA; Ryu D; Kwak MK
    Redox Biol; 2019 Jun; 24():101210. PubMed ID: 31078780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intrinsically lower AKT, mammalian target of rapamycin, and hypoxia-inducible factor activity correlates with increased sensitivity to 2-deoxy-D-glucose under hypoxia in lung cancer cell lines.
    Wangpaichitr M; Savaraj N; Maher J; Kurtoglu M; Lampidis TJ
    Mol Cancer Ther; 2008 Jun; 7(6):1506-13. PubMed ID: 18566221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppression of the proliferation of hypoxia-Induced retinal pigment epithelial cell by rapamycin through the /mTOR/HIF-1α/VEGF/ signaling.
    Liu NN; Zhao N; Cai N
    IUBMB Life; 2015 Jun; 67(6):446-52. PubMed ID: 25988388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apoptotic effects of high-dose rapamycin occur in S-phase of the cell cycle.
    Saqcena M; Patel D; Menon D; Mukhopadhyay S; Foster DA
    Cell Cycle; 2015; 14(14):2285-92. PubMed ID: 25945415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drosophila larvae lacking the bcl-2 gene, buffy, are sensitive to nutrient stress, maintain increased basal target of rapamycin (Tor) signaling and exhibit characteristics of altered basal energy metabolism.
    Monserrate JP; Chen MY; Brachmann CB
    BMC Biol; 2012 Jul; 10():63. PubMed ID: 22824239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deregulated phospholipase D2/mammalian target of rapamycin/hypoxia-inducible factor 1 alpha in peripheral T lymphocytes of oral lichen planus correlated with disease severity.
    Wang F; Zhang J; Zhou G
    Arch Oral Biol; 2019 Feb; 98():26-31. PubMed ID: 30419486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.